CIBC Bancorp USA’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$282M Sell
1,073,526
-98,460
-8% -$26M 0.35% 61
2026
Q2
$259M Sell
1,171,986
-535,859
-31% -$148M 0.32% 70
2026
Q1
$504M Buy
+1,707,845
New +$507M 0.68% 25
2025
Q3
$14.9M Buy
+55,330
New +$15.1M 0.08% 192

Other funds holding CME

CIBC Bancorp USA's CME Position: Q3 2026 in Review

CIBC Bancorp USA reduced its CME Group (CME) stake by 8.4% in Q3 2026, selling an estimated $26M and leaving 1,073,526 shares worth $282M. The position accounts for 0.35% of the portfolio, ranked #61.

CIBC Bancorp USA first reported a position in CME in Q3 2025 and has held it in 4 quarters since. The position peaked at $504M in Q1 2026. 1,768 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • CIBC Bancorp USA held 1,073,526 shares of CME Group worth $282M as of Q3 2026.
  • CIBC Bancorp USA sold 98,460 CME Group shares in Q3 2026, an estimated $26M.
  • CME Group made up 0.35% of CIBC Bancorp USA's portfolio in Q3 2026, its #61 holding.
  • CIBC Bancorp USA first reported a position in CME Group in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's CME Group position peaked at $504M in Q1 2026.
  • 1,768 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.